FDA Investigator Maria Gutierrez Lugo, PhD

Maria Gutierrez Lugo, PhD has inspections in 4 countries as of 01 Sep 2023. Maria Gutierrez Lugo, PhD has collaborated with a combinined 3166 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
7
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
India, United States of America, Austria
Co-Investigator(s):
Adaliz Santaliz Cruz, Alan A Rivera, Alice S Tsao, Alicia M Mozzachio, Amy Devlin, PhD, Anastasia G Lolas, Andrea George, PhD, Andrea Siegel, PhD, Anita Narula, PhD, Anjali Shukla, PhD, Arlene M Badillo, Arsen Karapetyan, Ashley N Queen, PhD, Barbara Janine Breithaupt, Benjamin J Smith, Bijoy Panicker, Bo Chi, PhD, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Calvin B Koerner, Chaltu N Wakijra, Charanjeet Jassal, Christopher Downey, PhD, Colleen Thomas, PhD, David G Eng, Deborah Schmiel, PhD, Dennis Cantellops Paite, Diane L Raccasi, Dogbeda F Mackenzie, Donald C Obenhuber, PhD, Douglas A Campbell, Dov Pluznik, PhD, Dr. Barbara D Paul, PhD, Dr. Ralph M Bernstein, PhD, Edmund F Mrak, Jr, Eileen A Liu, Eliezar Ramos, Emest F Bizjak, Erika V Butler, Frances Namuswe, PhD, Geneve M Maxwell, Geneve M Parks, Gwyn G Dickinson, Howard Anderson, PhD, Hyung Yul Lee, Ivis Lnegron Torres, Jacek Cieslak, PhD, James D Bridges, James I Giefer, Jazmine N Still, Jee Chung, PhD, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey P Raimondi, Jennifer C Adams, Jennifer Lalama, Jennifer Swisher, PhD, Jerri Baker, Joel D Martinez, Jonathan W Chapman, Jorge L Lajara, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose R Lopez, Jose Velez, Kalavati Suvarna, PhD, Kathy Lee, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kristen Nickens, PhD, Lakshmi Narasimhan, PhD, Larry K Austin, Laura Fontan, MS, Laurel A Beer, Laurie Nelson, Lawrence J Stringer, Libia M Lugo, Linda F Murphy, Lindsey Brown, PhD, LT Rafael Gonzalez, LT Richard A Lyght, Lucila B Nwatu, Luis A Dasta, Madushini Dharmasena, PhD, Margaret M Annes, Maria Joselopez Barragan, PhD, Marian E Ramirez, Marion Michaelis, Mary E Farbman, PhD, Matthew B Casale, Maxwell Van Tassell, PhD, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Merry Christie, PhD, Michael A Charles, Michael G Truchan, Michael Shanks, MS, Michele L Forster, PhD, Michelle Y Clark Stuart, Milva E Melendez, Milva Emelendez Perales, Monica Markovski, PhD, Muralidhara B Gavini, PhD, Myriam M Sosa, Nebil A Oumer, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Patricia Fhughes Troost, Patrick J Lynch, Patrick L Wisor, Patsy J Domingo, Paul A Bonneau, Paul Z Balcer, Paula A Trost, Phillip Angart, PhD, Prabhu P Raju, Rachel C Harrington, Ramesh Potla, PhD, Ramon A Hernandez, Reba A Gates, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert Darius, Robert M Barbosa, S Lori Brown, PhD MPH, Sandra A Hughes, Santos E Camara, Sarah Arden, Sarah Kennett, PhD, Scott R Nichols, PhD, Shadia Zaman, PhD, Stephen D Eich, Steven C Madzo, Steven E Bowen, PhD, Steven Fong, MS, PhD, Susan M Jackson, Susanne M Richardson, MSc RAC ELS, Susant Hadman, Thomas J Arista, Thuy T Nguyen, LCDR, Thuy Y Nguyen, Timothy Wadkin, PhD, Vilmary Negron Rodriguez, Virginia Carroll, PhD, Wayne E Seifert, Wendy G Tan, PhD, Xianghong Jing (Emily), PhD, Xiaoshi Wang, Yun Wu, PhD, Zachary L Stamm, Zhenzhen Liu, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Maria Gutierrez Lugo, PhD's Documents

Publish Date Document Type Title
April, 2017 FDA 483 Biocon Biologics Limited - Form 483, 2017-04-07
September, 2019 FDA 483 Samsung Biologics Co., Ltd. - Form 483, 2019-09-10
September, 2014 FDA 483 Sandoz GmbH - Form 483, 2014-09-16
April, 2017 FDA 483 Biocon Limited - Form 483, 2017-04-03
March, 2014 FDA 483 Amgen Manufacturing Ltd - Form 483, 2014-03-29
July, 2015 FDA 483 Human Genome Sciences, Inc. - Form 483, 2015-07-24
April, 2013 FDA 483 Exelead, Inc. - Form 483, 2013-04-19

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more